Developed by the American company Eli Lilly, Tirzepatide is a dual agonist for both the glucose-dependent insulinotropic polypeptide (GIP) receptor and the GLP-1 receptor
Its primary function is to help regulate blood sugar levels by enhancing the effects of the naturally occurring GLP-1 hormone
Bottom line on Medicare GLP-1 coverage If you qualify, you have a Part D plan, the $50 is manageable on top of your other drug spending, and you are not on Extra Help, the Bridge is the best deal on the market for Medicare-eligible patients right now
In selecting our winner overall and the winners for various subcategories included in our summary of recommendations, we gave the most weight to effectiveness, and safety was close behind
Liu C, Li J, Zhang Y et al (2015a) Influence of glucose fermentation on CO2 assimilation to acetate in homoacetogen Blautia coccoides GA-1
3A) and liver lipid content (Fig